Home Fisetin effects on cell proliferation and apoptosis in glioma cells
Article
Licensed
Unlicensed Requires Authentication

Fisetin effects on cell proliferation and apoptosis in glioma cells

  • Fulya Pak and Pinar Oztopcu-Vatan EMAIL logo
Published/Copyright: August 17, 2019
Become an author with De Gruyter Brill

Abstract

This research investigated the antiproliferative effects of 1–500 μM fisetin in T98G and BEAS-2B cells by MTT assay. The IC50 of fisetin in T98G cells for 24 and 48 h were 93 and 75 μM, respectively. Apoptotic alterations of fisetin-treated T98G cells were observed by transmission electron microscopy. BEAS-2B was then used in comparison to T98G cells to determine the cytotoxic effects of fisetin. The IC50 of fisetin for 24 and 48 h were recorded as 270 and 90 μM in BEAS-2B cells, respectively. Different concentrations of fisetin were selected to determine the apoptotic and necrotic effects. Consequently, fisetin was determined to have more apoptotic effects in T98G than BEAS-2B cells, dose- and time-dependently. Moreover, fisetin was found to have cytotoxicity at lower doses in T98G cells compared to carmustine, as positive control. CASPASE 3, CASPASE 9, CASPASE 8, and BAX expressions were increased by the selected fisetin doses of 25 and 50 μM, while that of BCL-2 and survivin was reduced in T98G cells. These results will serve as an essential basis of future in vitro and in vivo studies, in the continuous search for alternative treatment agents for gliomas.

Acknowledgements

This publication was based completely on M.Sc. thesis of the first author. The study was supported by Eskisehir Osmangazi University Scientific Research Projects Committee (project no. 201319A112).

  1. Conflict of interest: The authors declare no conflict of interest.

References

1. Ponder BA. Cancer genetics. Nature 2001;411:336–41.10.1038/35077207Search in Google Scholar PubMed

2. Maher EA, Brennan C, Wen PY, Durso L, Ligon KL, Richardson A, et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res 2006;66:11502–13.10.1158/0008-5472.CAN-06-2072Search in Google Scholar PubMed

3. Das A, Banik NL, Ray SK. N-(4-hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res 2008;1227:207–15.10.1016/j.brainres.2008.06.045Search in Google Scholar PubMed PubMed Central

4. Reithmeier T, Graf E, Piroth T, Trippel M, Pinsker MO, Nikkhah G. BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors. BMC Cancer 2010;10:30.10.1186/1471-2407-10-30Search in Google Scholar PubMed PubMed Central

5. Choi EJ. Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21. Nutr Cancer 2007;59:115–9.10.1080/01635580701419030Search in Google Scholar PubMed

6. Ben Sghaier M, Skandrani I, Nasr N, Franca MG, Chekir-Ghedira L, Ghedira K. Flavonoids and sesquiterpenes from Tecurium ramosissimum promote antiproliferation of human cancer cells and enhance antioxidant activity: a structure–activity relationship study. Environ Toxicol Pharmacol 2011;32:336–48.10.1016/j.etap.2011.07.003Search in Google Scholar PubMed

7. Kashyap D, Sharma A, Sak K, Tuli HS, Buttar HS, Bishayee A. Fisetin: a bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci 2018;194:75–87.10.1016/j.lfs.2017.12.005Search in Google Scholar PubMed

8. Constantin RP, Constantin J, Pagadigorria CL, Ishii-Iwamoto EL, Bracht A, de Castro CV, et al. Prooxidant activity of fisetin: effects on energy metabolism in the rat liver. J Biochem Mol Toxicol 2011;25:117–26.10.1002/jbt.20367Search in Google Scholar PubMed

9. Touil YS, Seguin J, Scherman D, Chabot GG. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma–bearing mice. Cancer Chemother Pharmacol 2011;68:445–55.10.1007/s00280-010-1505-8Search in Google Scholar PubMed PubMed Central

10. Ying T-H, Yang S-F, Tsai S-J, Hsieh SC, Huang YC, Bau DT, et al. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3–dependent pathway. Arch Toxicol 2012;86:263–73.10.1007/s00204-011-0754-6Search in Google Scholar PubMed

11. Haddad AQ, Fleshner N, Nelson C, Saour B, Musquera M, Venkateswaran V, et al. Antiproliferative mechanisms of the flavonoids 2,2′-dihydroxychalcone and fisetin in human prostate cancer cells. Nutr Cancer 2010;62:668–81.10.1080/01635581003605524Search in Google Scholar PubMed

12. Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H, et al. Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin Pharmacol Toxicol 2011;108:84–93.10.1111/j.1742-7843.2010.00613.xSearch in Google Scholar PubMed

13. Kim JY, Jeon YK, Jeon W, Nam MJ. Fisetin induces apoptosis in Huh-7 cells via downregulation of BIRC8 and Bcl2L2. Food Chem Toxicol 2010;48:2259–64.10.1016/j.fct.2010.05.058Search in Google Scholar PubMed

14. Lee S, Kim Y-J, Kwon S, Lee Y, Choi SY, Park J, et al. Inhibitory effects of flavonoids on TNF-alpha–induced IL-8 gene expression in HEK 293 cells. BMB Rep 2009;42:265–70.10.5483/BMBRep.2009.42.5.265Search in Google Scholar PubMed

15. Oztopcu-Vatan P, Sayitoglu M, Gunindi M, Inan E. Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells. Cytotechnology 2015;67:1003–9.10.1007/s10616-014-9739-7Search in Google Scholar PubMed PubMed Central

16. Harhaji-Trajkovic L, Vilimanovich U, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V. AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J Cell Mol Med 2009;13:3644–54.10.1111/j.1582-4934.2009.00663.xSearch in Google Scholar PubMed PubMed Central

17. Yildiz-Ozer M, Oztopcu-Vatan P, Kus G. The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro. Cytotechnology 2018;70:387–96.10.1007/s10616-017-0154-8Search in Google Scholar PubMed PubMed Central

18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008;3:1101–8.10.1038/nprot.2008.73Search in Google Scholar PubMed

19. Brunetti A, Marinelli O, Morelli MB, Iannarelli R, Amantini C, Russotti D, et al. Isofuranodiene synergizes with temozolomide in inducing glioma cells death. Phytomedicine 2019;52:51–9.10.1016/j.phymed.2018.09.220Search in Google Scholar PubMed

20. So FV, Guthrie N, Chambers AF, Carroll KK. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 1997;112:127–33.10.1016/S0304-3835(96)04557-0Search in Google Scholar PubMed

21. Chen Y-C, Shen S-C, Lee W-R, Lin HY, Ko CH, Shih CM, et al. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol 2002;76:351–9.10.1007/s00204-002-0346-6Search in Google Scholar PubMed

22. Lu X, Jung Ji, Cho HJ, Lim DY, Lee HS, Chun HS, et al. Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J Nutr 2005;135:2884–90.10.1093/jn/135.12.2884Search in Google Scholar PubMed

23. Chen C-M, Hsieh Y-H, Hwang J-M, Jan HJ, Hsieh SC, Lin SH, et al. Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2. Tumor Biol 2015;36:3407–15.10.1007/s13277-014-2975-9Search in Google Scholar PubMed

24. Adan A, Baran Y. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks. Tumor Biol 2015;36:8973–84.10.1007/s13277-015-3597-6Search in Google Scholar PubMed

25. Sun X, Ma X, Li Q, Yang Y, Xu X, Sun J, et al. Anti-cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: in vitro and in vivo studies. Int J Mol Med 2018;42:811–20.10.3892/ijmm.2018.3654Search in Google Scholar PubMed PubMed Central

26. Szeliga M, Zgrzywa A, Obara-Michlewska M, Albrecht J. Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents. J Neurochem 2012;123:428–36.10.1111/j.1471-4159.2012.07917.xSearch in Google Scholar PubMed

27. Khan N, Afaq F, Syed DN, Mukhtar H. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis 2008;29:1049–56.10.1093/carcin/bgn078Search in Google Scholar PubMed PubMed Central

28. Klimaszewska-Wisniewska A, Halas-Wisniewska M, Tadrowski T, Gagat M, Grzanka D, Grzanka A. Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non–small cell lung cancer cells. Cancer Cell Int 2016;16:10.10.1186/s12935-016-0288-3Search in Google Scholar PubMed PubMed Central

29. Kim S, Choi KJ, Cho S-J, Yun SM, Jeon JP, Koh YH, et al. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Sci Rep 2016;6:24933.10.1038/srep24933Search in Google Scholar PubMed PubMed Central

30. Park B-S, Choi N-E, Lee JH, Kang HM, Yu SB, Kim HJ, et al. Crosstalk between fisetin-induced apoptosis and autophagy in human oral squamous cell carcinoma. J Cancer 2019;10:138–46.10.7150/jca.28500Search in Google Scholar PubMed PubMed Central

31. Youns M, Abdel Halim Hegazy W. The natural flavonoid fisetin inhibits cellular proliferation of hepatic, colorectal, and pancreatic cancer cells through modulation of multiple signaling pathways. PLoS One 2017;2:e0169335.10.1371/journal.pone.0169335Search in Google Scholar PubMed PubMed Central

32. Lee W-R, Shen S-C, Lin H-Y, Hou WC, Yang LL, Chen YC. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca2+-dependent endonuclease. Biochem Pharmacol 2002;63:225–36.10.1016/S0006-2952(01)00876-0Search in Google Scholar

Received: 2019-05-16
Revised: 2019-07-12
Accepted: 2019-07-18
Published Online: 2019-08-17
Published in Print: 2019-11-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 25.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2019-0098/html
Scroll to top button